Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(882/week)
    • Manufacturing(441/week)
    • Energy(335/week)
    • Technology(888/week)
    • Environment(373/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Hodgkin's lymphoma

Jan 02, 2019
Global Peripheral T-Cell Lymphoma (PTCL) Report 2018: Market Insights, Epidemiology and Market Forecast 2016-2027 Featuring AB Science, Celgene, CerRx & Onxeo S.A.
Dec 27, 2018
JHL Biotech Announces First Patient Randomized in the Phase III Study of JHL1101 to Treat Diffuse Large B-Cell Lymphoma
Dec 27, 2018
Xynomic Pharma Will Present at ASCO-GU Cancers Symposium, Files 3 INDs for Potentially Pivotal Cancer Trials in China, and Expands R&D Operations
Dec 17, 2018
Volcani Center Announces Significant Breakthroughs in CTCL Skin Cancer Cannabis Treatment Development in Cooperation With MedC Biopharma Corporation of Canada
Dec 04, 2018
Children's Cancer and Blood Foundation Breakthrough Ball
Dec 03, 2018
Nordic Nanovector: Additional Preclinical Studies With CD37-targeting Radioimmunotherapies for B-cell Malignancies Presented at ASH
Dec 03, 2018
Arix Bioscience plc: Autolus Announces Update on AUTO4 and AUTO5 Programmes
Dec 02, 2018
Nordic Nanovector: Single Administration Betalutin® is Effective and Well-tolerated in R/R iNHL Patients: 6 Month Follow-up Data Presented at ASH
Nov 16, 2018
FDA approves first-line treatment for peripheral T-cell lymphoma under new review pilot
Nov 02, 2018
Nordic Nanovector Announces First Patient Dosed in Archer-1 Trial of Betalutin® Plus Rituximab in Follicular Lymphoma
Oct 26, 2018
Global Non-Hodgkin Lymphoma Market and Competitive Landscape - 2018
Oct 26, 2018
Nordic Nanovector Announces Opening of First US Site for PARADIGME Trial of Betalutin® in Third-line Follicular Lymphoma
Oct 25, 2018
Nordic Nanovector's Betalutin® Receives Promising Innovative Medicine (PIM) Designation in the UK for the Treatment of Follicular Lymphoma
Oct 12, 2018
Nordic Nanovector Presentations at the Annual Congress of the European Association of Nuclear Medicine (EANM)
Oct 10, 2018
The Leukemia & Lymphoma Society Receives Significant Gift to Support Promising Young Scientists
Sep 11, 2018
Global B-cell Non Hodgkin Lymphoma Drugs Market 2018-2022: Key Vendors are Biogen, F. Hoffmann-La Roche, Merck, Novartis & Spectrum Pharmaceuticals
Sep 11, 2018
Global B-cell non hodgkin lymphoma drugs market 2018-2022
Sep 04, 2018
Golf Outing: Ice Mobility Announces 3rd Annual Charity Golf Outing Benefiting the Leukemia and Lymphoma Society
Aug 13, 2018
Sutro and The Leukemia & Lymphoma Society Partner on Lymphoma and Multiple Myeloma Treatment
Aug 08, 2018
FDA approves treatment for two rare types of non-Hodgkin lymphoma
  • ‹‹
  • Page 2
  • ››

Latest News

May 29, 2025

Verdant Commercial Capital Successfully Closes Fourth Asset-Backed Securitization for $400.6 Million

May 29, 2025

From Ancient Grounds to an Intelligent Future: The 1st International Humanoid Olympiad Launches in Olympia,...

May 29, 2025

Avantus Appoints David Flory as CFO to Support Next Phase of Growth

May 29, 2025

ATS Reports Fourth Quarter and Fiscal 2025 Results

May 29, 2025

Lithium Royalty Corp. Announces Voting Results

May 29, 2025

Argonne's Virtual Models Pave the Way for Advanced Nuclear Reactors

May 29, 2025

Nordson Corporation Reports Second Quarter Fiscal 2025 Results and Third Quarter Guidance

May 29, 2025

Mary Kay Inc. Awards 10 Grants to Young Innovators at 2025 Regeneron International Science and Engineering...

View all News

Agenda

23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia